HIV remains the most dangerous sexually transmitted infection because, without treatment, it destroys the immune system and is fatal. But “worst” depends on what you measure. HIV kills the most people. HPV causes the most cancers. Hepatitis B causes the most chronic organ damage worldwide. And gonorrhea is rapidly becoming untreatable. Here’s how the most serious STIs compare across the dimensions that actually matter: mortality, cancer risk, organ damage, and treatability.
HIV: The Highest Mortality Risk
HIV is the only STI that, left untreated, is universally fatal. It progressively destroys immune cells until the body can no longer fight off infections or cancers, a stage known as AIDS. Before effective treatment existed, most people died within a decade of infection.
Modern antiretroviral therapy has transformed HIV into a manageable chronic condition, but it hasn’t erased the damage. A UK study published in The BMJ found that even with treatment, life expectancy for men diagnosed with HIV was about 39.5 years from the point of diagnosis at age 20, compared to 57.8 years for men in the general population. Women fared somewhat better but still lost roughly 11 years. Starting treatment late, after the immune system has already taken a serious hit, cost patients up to 15 additional years of life compared to those who began treatment earlier.
The critical factor is diagnosis. People who learn their status early and start treatment promptly can expect to live decades. Those who don’t know they’re infected, or who can’t access care, face the same grim prognosis people faced in the 1980s. Globally, HIV still kills hundreds of thousands of people every year, almost entirely in settings where testing and treatment aren’t widely available.
HPV: The Leading Cause of STI-Related Cancer
Human papillomavirus doesn’t make headlines the way HIV does, but it causes more cancer than any other sexually transmitted infection. Virtually all cervical cancer is caused by HPV, and about 70% of throat cancers are as well. The virus also drives a significant share of cancers of the anus, penis, vagina, and vulva.
There are 12 high-risk HPV strains, but two of them (types 16 and 18) are responsible for most HPV-related cancers. The danger with HPV is its invisibility. Most infections cause no symptoms and clear on their own within a year or two. The small percentage that persist can quietly trigger cellular changes over 10 to 20 years before cancer develops. By the time symptoms appear, the disease may be advanced.
HPV vaccination prevents infection with the highest-risk strains and has already begun reducing cervical cancer rates in countries with high vaccination coverage. Regular screening (Pap smears and HPV tests) catches precancerous changes early enough to treat them before they progress. Without either of those safeguards, HPV is arguably the most destructive STI in terms of sheer numbers of people harmed.
Hepatitis B: Chronic Liver Destruction
An estimated 254 million people worldwide were living with chronic hepatitis B in 2022, making it one of the most common chronic infections on the planet. While many people clear the virus on their own after the initial infection, those who don’t face a slow, progressive assault on the liver that can span decades.
The annual rate of developing cirrhosis (severe scarring of the liver) among people with chronic hepatitis B ranges from about 2% to 7% per year, depending on the viral load. Over a lifetime, cumulative cirrhosis risk can reach 36% in people with high viral levels. Cirrhosis, in turn, significantly raises the risk of liver cancer and liver failure. Hepatitis B is one of the leading causes of liver cancer globally.
A vaccine has been available since the 1980s and is extremely effective. For those already chronically infected, antiviral medications can suppress the virus and slow liver damage, but they rarely eliminate it entirely. Hepatitis B is particularly dangerous because many people don’t know they carry it until liver damage is already advanced.
Hepatitis C: Curable but Still Dangerous
Hepatitis C follows a similar path to hepatitis B, silently damaging the liver over years or decades. It causes cirrhosis, liver cancer, and liver failure, and was historically a leading reason for liver transplants. What sets it apart is a remarkable medical advance: direct-acting antiviral medications now cure more than 95% of hepatitis C infections in just 8 to 12 weeks of oral treatment.
That cure rate makes hepatitis C far less threatening than it was even 15 years ago, when treatment involved months of harsh injections with cure rates below 50%. The remaining danger is the same as with HIV and hepatitis B: people who don’t know they’re infected can’t get treated. Many people with hepatitis C have no symptoms for decades until liver damage becomes severe.
Syphilis: A Resurgent Threat
Syphilis nearly disappeared in wealthy countries by the early 2000s but has surged back dramatically. An estimated 8 million adults were infected in 2022, and 1.1 million pregnant women had active syphilis that year, resulting in over 390,000 adverse birth outcomes including stillbirths, neonatal deaths, and congenital infections.
Untreated syphilis progresses through stages over years. Early stages cause painless sores and rashes that resolve on their own, which tricks many people into thinking they’ve recovered. But the bacteria remain in the body and can eventually invade the brain, heart, blood vessels, and bones. Late-stage syphilis, once called “the great imitator” because it mimics so many other diseases, can cause dementia, blindness, paralysis, and death.
The good news is that syphilis is still easily cured with penicillin, especially in its early stages. The bad news is that its early symptoms are easy to miss or ignore, and rates are climbing fastest among populations with limited access to regular screening.
Gonorrhea: Racing Toward Untreatable
Gonorrhea itself isn’t typically fatal, but it’s becoming one of the most alarming STIs because of how rapidly it’s outrunning antibiotics. Between 2022 and 2024, resistance to the two primary antibiotics used to treat gonorrhea rose sharply: resistance to one jumped from 0.8% to 5%, and resistance to the other climbed from 1.7% to 11%. Resistance to an older antibiotic, ciprofloxacin, has reached 95%, making it essentially useless.
If gonorrhea becomes fully resistant to all available antibiotics, the consequences would be severe. Untreated gonorrhea can cause pelvic inflammatory disease in women, which scars the fallopian tubes and leads to infertility. After three episodes of pelvic inflammatory disease, more than 50% of women develop tubal dysfunction that prevents pregnancy. In men, untreated gonorrhea can cause painful inflammation of the reproductive tract and, rarely, spread to the blood and joints.
With 82 million new gonorrhea infections estimated worldwide each year, antibiotic resistance in this pathogen is considered a major global health threat.
Chlamydia and Other “Silent” STIs
Chlamydia is the most common bacterial STI, with an estimated 129 million new infections per year. It rarely causes dramatic symptoms, which is precisely what makes it dangerous. Up to 70% of women and 50% of men with chlamydia have no symptoms at all. Left untreated, it causes the same pelvic inflammatory disease and infertility risks as gonorrhea.
A newer concern is Mycoplasma genitalium, a lesser-known bacterium that causes urethritis and pelvic inflammatory disease. It’s becoming increasingly difficult to treat. Resistance to the first-choice class of antibiotics ranges from 44% to 90% in the U.S., Canada, Western Europe, and Australia. Cure rates above 90% are still possible when doctors test for resistance patterns before prescribing, but that testing isn’t yet widely available.
How “Worst” Depends on Your Situation
If you’re asking which STI is most likely to kill you, the answer is HIV. If you’re asking which causes the most cancer, it’s HPV. If you’re asking which causes the most chronic organ damage worldwide, hepatitis B. If you’re asking which poses the scariest near-term public health threat, it’s drug-resistant gonorrhea.
The common thread across all of these is that the worst outcomes happen when infections go undetected. HIV, hepatitis B, hepatitis C, HPV, syphilis, chlamydia, and gonorrhea can all progress silently for months or years. Regular screening is the single most effective way to catch them before they cause irreversible damage. Vaccines exist for HPV and hepatitis B, and both prevent the most serious consequences of those infections entirely.